Cambridge Raman Imaging in the Spotlight: Insights from Our Interim CEO
We are pleased to share that Francesco Crisafi, Interim CEO and CTO of Cambridge Raman Imaging, was recently interviewed in Novus Light…
News
CRI shines at ICORS 2024 in Rome
Matteo Negro and Giulio Cerullo delve into the transformative potential of coherent Raman scattering microscopy in pharmaceutical production and drug discovery.
CRI’s CEO and co-founder discuss the potential of Raman microscopy in pharmaceutical industry
Matteo Negro and Giulio Cerullo delve into the transformative potential of coherent Raman scattering microscopy in pharmaceutical production and drug discovery.
CRI showcases new products and CHARM project at San Francisco conference
Cambridge Raman Imaging, showcases heir recently developed laser and microscopy products at SPIE Photonics West BiOS conference in San Francisco.
CRI presents project Mindset, the future of virtual histopathology
The project The MINDSET project – MicroscopIa RamaN Coerente per istopatologia e DiagnoSi dEi Tumori (in English: Coherent Raman Microscopy for histopathology…
Cambridge Raman Imaging presents new technology at Frontier IP Showcase
Developing new medical technologies based on high-speed, low-cost Raman digital imaging and artificial intelligence has the potential to transform cancer diagnosis and…
CRI is featured in the Market Map of the leading European healthcare companies
< Glad to be featured in the Market Map of the leading European healthcare companies 2022 curated by AlbionVC – which aims…
CRI raises 1.1 million to accelerate scale up through an equity funding round
Cambridge Raman Imaging has raised £1.1 million through an equity funding round from existing and new investors, bringing CRI value at £6.1…
Cambridge Raman Imaging has been selected to coordinate a European Union grant to transform cancer diagnosis and treatment
Cambridge Raman Imaging (“CRI” or the “Company”) announces today it will coordinate a project selected to receive a €3.3 million grant in…